76 related articles for article (PubMed ID: 25502777)
21. Genome-wide analysis of pancreatic cancer using microarray-based techniques.
Harada T; Chelala C; Crnogorac-Jurcevic T; Lemoine NR
Pancreatology; 2009; 9(1-2):13-24. PubMed ID: 19077451
[TBL] [Abstract][Full Text] [Related]
22. Novel technology for detection of genomic and transcriptional alterations in pancreatic cancer.
Wallrapp C; Müller-Pillasch F; Micha A; Wenger C; Geng M; Solinas-Toldo S; Lichter P; Frohme M; Hoheisel JD; Adler G; Gress TM
Ann Oncol; 1999; 10 Suppl 4():64-8. PubMed ID: 10436788
[TBL] [Abstract][Full Text] [Related]
23. Identification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization.
Liang JW; Shi ZZ; Shen TY; Che X; Wang Z; Shi SS; Xu X; Cai Y; Zhao P; Wang CF; Zhou ZX; Wang MR
PLoS One; 2014; 9(12):e114616. PubMed ID: 25502777
[TBL] [Abstract][Full Text] [Related]
24. Genomic landscape of pancreatic neuroendocrine tumors.
Gebauer N; Schmidt-Werthern C; Bernard V; Feller AC; Keck T; Begum N; Rades D; Lehnert H; Brabant G; Thorns C
World J Gastroenterol; 2014 Dec; 20(46):17498-506. PubMed ID: 25516664
[TBL] [Abstract][Full Text] [Related]
25. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.
Suzuki A; Shibata T; Shimada Y; Murakami Y; Horii A; Shiratori K; Hirohashi S; Inazawa J; Imoto I
Cancer Sci; 2008 May; 99(5):986-94. PubMed ID: 18380791
[TBL] [Abstract][Full Text] [Related]
26. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
27. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer.
Bashyam MD; Bair R; Kim YH; Wang P; Hernandez-Boussard T; Karikari CA; Tibshirani R; Maitra A; Pollack JR
Neoplasia; 2005 Jun; 7(6):556-62. PubMed ID: 16036106
[TBL] [Abstract][Full Text] [Related]
28. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
[TBL] [Abstract][Full Text] [Related]
29. Expression of HMGA2 in bladder cancer and its association with epithelial-to-mesenchymal transition.
Ding X; Wang Y; Ma X; Guo H; Yan X; Chi Q; Li J; Hou Y; Wang C
Cell Prolif; 2014 Apr; 47(2):146-51. PubMed ID: 24571540
[TBL] [Abstract][Full Text] [Related]
30. Effects of HMGA2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells.
Xi YN; Xin XY; Ye HM
Asian Pac J Trop Med; 2014 Apr; 7(4):289-92. PubMed ID: 24507678
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
Leonard B; Hart SN; Burns MB; Carpenter MA; Temiz NA; Rathore A; Vogel RI; Nikas JB; Law EK; Brown WL; Li Y; Zhang Y; Maurer MJ; Oberg AL; Cunningham JM; Shridhar V; Bell DA; April C; Bentley D; Bibikova M; Cheetham RK; Fan JB; Grocock R; Humphray S; Kingsbury Z; Peden J; Chien J; Swisher EM; Hartmann LC; Kalli KR; Goode EL; Sicotte H; Kaufmann SH; Harris RS
Cancer Res; 2013 Dec; 73(24):7222-31. PubMed ID: 24154874
[TBL] [Abstract][Full Text] [Related]
32. A biochemical analysis linking APOBEC3A to disparate HIV-1 restriction and skin cancer.
Pham P; Landolph A; Mendez C; Li N; Goodman MF
J Biol Chem; 2013 Oct; 288(41):29294-304. PubMed ID: 23979356
[TBL] [Abstract][Full Text] [Related]
33. Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death.
Mussil B; Suspène R; Aynaud MM; Gauvrit A; Vartanian JP; Wain-Hobson S
PLoS One; 2013; 8(8):e73641. PubMed ID: 23977391
[TBL] [Abstract][Full Text] [Related]
34. Evidence for APOBEC3B mutagenesis in multiple human cancers.
Burns MB; Temiz NA; Harris RS
Nat Genet; 2013 Sep; 45(9):977-83. PubMed ID: 23852168
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
[TBL] [Abstract][Full Text] [Related]
36. HMGA2 is a driver of tumor metastasis.
Morishita A; Zaidi MR; Mitoro A; Sankarasharma D; Szabolcs M; Okada Y; D'Armiento J; Chada K
Cancer Res; 2013 Jul; 73(14):4289-99. PubMed ID: 23722545
[TBL] [Abstract][Full Text] [Related]
37. HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.
Sun M; Song CX; Huang H; Frankenberger CA; Sankarasharma D; Gomes S; Chen P; Chen J; Chada KK; He C; Rosner MR
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9920-5. PubMed ID: 23716660
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
